发明名称 |
CNS DELIVERY OF THERAPEUTIC AGENTS |
摘要 |
PROBLEM TO BE SOLVED: To provide a CNS delivery of therapeutic agents.SOLUTION: The invention provides an effective and less invasive approach for direct delivery of therapeutic agents to the central nervous system (CNS). In some embodiments, the invention provides methods comprising a step of intrathecally administering a composition containing the anaplerotic enzyme of a lysosomal enzyme to a subject suffering from or susceptible to a lysosomal storage disease associated with reduced level or activity of the lysosomal enzyme. Many lysosomal storage disorders affect the nervous system, and thus we demonstrate unique challenges in treating these diseases with traditional therapies.SELECTED DRAWING: None |
申请公布号 |
JP2016037504(A) |
申请公布日期 |
2016.03.22 |
申请号 |
JP20150236539 |
申请日期 |
2015.12.03 |
申请人 |
SHIRE HUMAN GENETIC THERAPIES INC |
发明人 |
PERICLES CALIAS;PAN JING;JAN POWELL;LAWRENCE CHARNAS;THOMAS MCCAULEY;TERESA LEAH WRIGHT;RICHARD PFEIFER;SHAHROKH ZAHRA |
分类号 |
A61K38/43;A61M5/142;A61M37/00;A61P1/08;A61P1/16;A61P3/00;A61P9/00;A61P13/12;A61P19/00;A61P21/00;A61P25/00;A61P25/08;A61P25/14;A61P25/20;A61P25/28;A61P27/02;A61P27/16;A61P39/02;A61P43/00 |
主分类号 |
A61K38/43 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|